Literature DB >> 27175747

Lentivirus-mediated inhibition of USP39 suppresses the growth of gastric cancer cells via PARP activation.

Xinbao Wang1, Qiming Yu1, Ling Huang1, Pengfei Yu1.   

Abstract

Gastric cancer (GC) is the second most common cause of cancer-associated mortality worldwide. Ubiquitin-specific peptidase 39 (USP39) has important roles in mRNA processing and has been reported to be involved in the growth of breast cancer cells. However, the roles of USP39 in GC have remained to be investigated, which was the aim of the present study. A lentivirus expressing short hairpin RNA targeting USP39 was constructed and transfected into MGC80‑3 cells. Suppression of USP39 expression significantly decreased the proliferation and colony forming ability of MGC80‑3 cells as indicated by an MTT and a clonogenic assay, respectively. In addition, flow cytometric cell cycle analysis revealed that depression of USP39 induced G2/M‑phase arrest, while an intracellular signaling array showed that the cleavage of PARP at Asp214 was increased following USP39 knockdown. These results suggested that USP39 is involved in the proliferation of GCs and may be utilized as a molecular target for GC therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27175747     DOI: 10.3892/mmr.2016.5252

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

1.  Ubiquitin-specific peptidase 39 regulates the process of proliferation and migration of human ovarian cancer via p53/p21 pathway and EMT.

Authors:  Congcong Yan; Jiahui Yuan; Jiajia Xu; Gongye Zhang; Xiaomei Li; Bing Zhang; Tianhui Hu; Xiaohua Huang; Yubin Mao; Gang Song
Journal:  Med Oncol       Date:  2019-10-21       Impact factor: 3.064

2.  miR-133a, directly targeted USP39, suppresses cell proliferation and predicts prognosis of gastric cancer.

Authors:  Xiang Dong; Hailong Su; Feng Jiang; Haiyan Li; Guangwen Shi; Lijuan Fan
Journal:  Oncol Lett       Date:  2018-04-04       Impact factor: 2.967

3.  RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation.

Authors:  Kaikai Ding; Jianxiong Ji; Xin Zhang; Bin Huang; Anjing Chen; Di Zhang; Xingang Li; Xinyu Wang; Jian Wang
Journal:  Oncogene       Date:  2019-07-22       Impact factor: 9.867

Review 4.  Identifying Novel Actionable Targets in Colon Cancer.

Authors:  Maria Grazia Cerrito; Emanuela Grassilli
Journal:  Biomedicines       Date:  2021-05-20

Review 5.  The role of deubiquitinating enzymes in gastric cancer.

Authors:  Jiangang Sun; Xiaojing Shi; M A A Mamun; Yongshun Gao
Journal:  Oncol Lett       Date:  2019-11-07       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.